fundvisualizer.com

AXS Alternative Value InstitutionalCOGVX

Performance (before sales charge)

As of 12/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2022
Stock
135.42%
Non-U.S. Stock
3.73%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
-47.98%
Other
8.82%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2022

Basic materials

0.00%

Consumer cyclical

5.65%

Financial services

22.29%

Real estate

1.79%

Consumer defensive

38.79%

Health care

36.75%

Utilities

2.95%

Communication services

6.57%

Energy

2.30%

Industrials

10.66%

Technology

11.39%

Top 10 holdings

As of 09/30/2022

Bnp Borrowing
48.01%
Other
8.82%
Vertex Pharmaceuticals Inc
2.51%
General Mills Inc
2.30%
Coterra Energy Inc Ordinary Shares
2.30%
Biogen Inc
2.29%
The Hershey Co
2.27%
Regeneron Pharmaceuticals Inc
2.25%
Arthur J. Gallagher & Co
2.15%
Dollar General Corp
2.13%
Fund assets

$28.22 Million

Share class

Inst

Morningstar category

Large Value

Expense ratio

1.32%

Investment objective

Growth

Documents